Cargando…
Comparison of ramosetron with ondansetron for the prevention of post-operative nausea and vomiting in high-risk patients
BACKGROUND AND AIMS: Post-operative nausea and vomiting (PONV) has an 80% incidence in high-risk patients. This is despite the availability of several antiemetic drugs. Selective 5-hydroxytryptamine type 3 (5-HT(3)) receptor antagonists are considered first-line for prophylaxis, ondansetron being th...
Autores principales: | Agarkar, Sandip, Chatterjee, Aparna S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408650/ https://www.ncbi.nlm.nih.gov/pubmed/25937648 http://dx.doi.org/10.4103/0019-5049.154999 |
Ejemplares similares
-
Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients
por: Joo, Jin, et al.
Publicado: (2016) -
Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
por: Choi, Yong Seon, et al.
Publicado: (2012) -
A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures
por: Mujoo, Samiullah, et al.
Publicado: (2017) -
Comparison of equipotent doses of Ramosetron, Ondansetron, and sub-hypnotic dose of Propofol for prevention of postoperative nausea and vomiting in laparoscopic cholecystectomy
por: Acharya, Shilpa Amol, et al.
Publicado: (2021) -
Ondansetron, ramosetron, or palonosetron: Which is a better choice of antiemetic to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy?
por: Swaika, Sarbari, et al.
Publicado: (2011)